02:57:46 EDT Fri 10 Apr 2026
Enter Symbol
or Name
USA
CA



Else Nutrition Holdings Inc (2)
Symbol BABY
Shares Issued 46,450,014
Close 2026-04-09 C$ 0.045
Market Cap C$ 2,090,251
Recent Sedar+ Documents

Else Nutrition Holdings to be delisted from TSX May 8

2026-04-09 20:34 ET - News Release

Subject: Else Nutrition Holdings Inc. Word Document

File: '\\swfile\EmailIn\20260409 172353 Attachment News Release delisting.docx'

- 1 -

120955148v1

NEWS RELEASE

Else Nutrition Announces TSX Delisting and Intention to Seek Alternate Listing

Vancouver, British Columbia, April 9, 2026 - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) (the "Company") announces that it has received notice that the Toronto Stock Exchange ("TSX") will delist the Company's common shares and warrants effective at the close of market on May 8, 2026. The delisting follows a review by the TSX, pursuant to which the TSX determined that the Company no longer meets the TSX continued listing requirements.

The Company is considering options to request a further review of the delisting determination, with the aim of obtaining an additional period to remedy the identified listing requirements that are deficient. The Company is also reviewing options to list on an alternate Canadian stock exchange concurrently with delisting from the TSX.

The Company continues to conduct its business operations in the ordinary course including working to complete and replenish its product inventory in order to address increasing market demand. In parallel, the Company is engaged in ongoing and substantive interactions with the FDA in connection with its application for approval of its infant formula. The Company will provide additional updates on these items in due course

About Else Nutrition Holdings Inc.

Else Nutrition Holdings Inc. is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.

Awards and Recognition:

"2017 Best Health and Diet Solutions" award at Milan's Global Food Innovation Summit

#1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler Formula Category

"Best Dairy Alternative" Award 2021 at World Plant-Based Expo

Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle category

During September 2022, Else Super Cereal reached the #1 Best Seller in Baby Cereal across all brands on Amazon

For more information, visit www.elsenutrition.com or @elsenutrition on Facebook and Instagram.

For more information, contact:

Mrs. Hamutal Yitzhak, CEO, Co-Founder & Director

ELSE Nutrition Holdings Inc.

E: hamutaly@elsenutrition.com

P: +972(0)3-6445095

Neither the TSX nor its regulation services provider (as that term is defined in the policies of the TSX) accept responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will" or similar expressions. Forward-looking statements in this press release include statements with respect to further review of the delisting determination and the Company's intended application for a listing on alternate Canadian stock exchange. Such forward-looking statements reflect current estimates, beliefs, and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Actual results may differ from the estimates, beliefs, and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

© 2026 Canjex Publishing Ltd. All rights reserved.